Contemporary Therapeutic Approaches in the Cardiorenal-Metabolic Continuum: Current Perspectives on Diabetes, Chronic Kidney Disease, and Cardiovascular Dysfunction
International Science Journal · 28.06.2026 · 3 (1)
DOI: 10.64784/247 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Science Journal, online erschienen am 28.06.2026. Verfasst von Santiago Ávila Ak und 7 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Cardiorenal syndrome associated with type 2 diabetes mellitus has emerged as a major global health challenge due to its increasing prevalence, complex pathophysiology, and significant impact on morbidity and mortality. The interaction between cardiovascular disease, chronic kidney disease, and metabolic dysfunction creates a bidirectional cycle of organ damage mediated by inflammation, oxidative stress, endothelial dysfunction, neurohormonal activation, and fibrosis. This review analyzes current evidence regarding the mechanisms linking diabetes with cardiovascular and renal deterioration, emphasizing the concept of the cardiorenal-metabolic continuum. A comprehensive review of contemporary literature was conducted using international scientific databases and clinical practice guidelines. The findings indicate that recent therapeutic advances, particularly sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists, have significantly improved cardiovascular and renal outcomes while reducing disease progression and hospitalization rates. Despite these advances, substantial challenges remain regarding early diagnosis, treatment accessibility, therapeutic implementation, and healthcare disparities. These challenges are especially relevant in Latin American countries, including Mexico, Colombia, and Ecuador, where the burden of diabetes and chronic kidney disease continues to rise. Current evidence supports the adoption of integrated multidisciplinary approaches focused on early detection, comprehensive risk assessment, and evidence-based therapeutic interventions. The transition from organ-centered management toward a cardiorenal-metabolic model represents a fundamental paradigm shift that may contribute to improved patient survival, preservation of organ function, and enhanced quality of life.
Zitieren
APA
Ak, S. Á., Mendieta, R. D. Z., Lucas, C. W. F., Acevedo, L. M. M., Tolay, J. O., Godínez, E. F., Villagran, G. A., & Pérez, J. A. P. (2026). Contemporary Therapeutic Approaches in the Cardiorenal-Metabolic Continuum: Current Perspectives on Diabetes, Chronic Kidney Disease, and Cardiovascular Dysfunction. International Science Journal, 3(1). https://doi.org/10.64784/247
Vancouver
Ak SÁ, Mendieta RDZ, Lucas CWF, Acevedo LMM, Tolay JO, Godínez EF, et al. Contemporary Therapeutic Approaches in the Cardiorenal-Metabolic Continuum: Current Perspectives on Diabetes, Chronic Kidney Disease, and Cardiovascular Dysfunction. International Science Journal. 2026;3(1). doi:10.64784/247
BibTeX
@article{Ak2026,
author = {Ak, Santiago Ávila and Mendieta, Rafaela Denisse Zambrano and Lucas, Cristóbal Washington Franco and Acevedo, Luis Miguel Murgas and Tolay, Julian Ortega and Godínez, Erik Fernández and Villagran, Gerardo Amaya and Pérez, José Alberto Pérez},
title = {Contemporary Therapeutic Approaches in the Cardiorenal-Metabolic Continuum: Current Perspectives on Diabetes, Chronic Kidney Disease, and Cardiovascular Dysfunction},
journal = {International Science Journal},
year = {2026},
volume = {3},
number = {1},
doi = {10.64784/247}
}
EUVIMED